KeyBank National Association’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.54M Sell
27,985
-19,707
-41% -$1.08M 0.01% 487
2025
Q1
$3.37M Sell
47,692
-21,892
-31% -$1.55M 0.01% 339
2024
Q4
$4.57M Sell
69,584
-92,757
-57% -$6.1M 0.02% 301
2024
Q3
$11.4M Sell
162,341
-243,529
-60% -$17.1M 0.04% 217
2024
Q2
$33.4M Sell
405,870
-154,609
-28% -$12.7M 0.14% 130
2024
Q1
$49M Sell
560,479
-60,479
-10% -$5.28M 0.2% 105
2023
Q4
$59.9M Buy
620,958
+10,072
+2% +$971K 0.27% 81
2023
Q3
$54.1M Buy
610,886
+20,884
+4% +$1.85M 0.26% 86
2023
Q2
$51.1M Buy
590,002
+28,952
+5% +$2.51M 0.23% 91
2023
Q1
$54.6M Buy
561,050
+28,014
+5% +$2.72M 0.26% 84
2022
Q4
$55.2M Buy
533,036
+33,769
+7% +$3.49M 0.27% 84
2022
Q3
$42.3M Buy
499,267
+29,027
+6% +$2.46M 0.22% 100
2022
Q2
$39M Buy
470,240
+89,340
+23% +$7.4M 0.19% 108
2022
Q1
$29.4M Buy
380,900
+76,189
+25% +$5.87M 0.12% 146
2021
Q4
$26.9M Buy
304,711
+125,229
+70% +$11.1M 0.11% 148
2021
Q3
$13.9M Buy
179,482
+3,079
+2% +$238K 0.06% 189
2021
Q2
$14.7M Buy
176,403
+16,632
+10% +$1.39M 0.06% 183
2021
Q1
$12.1M Buy
159,771
+94,281
+144% +$7.12M 0.06% 191
2020
Q4
$5.74M Buy
65,490
+53,541
+448% +$4.7M 0.03% 249
2020
Q3
$909K Buy
11,949
+2,001
+20% +$152K ﹤0.01% 515
2020
Q2
$1.23M Buy
9,948
+1,800
+22% +$222K 0.01% 413
2020
Q1
$689K Sell
8,148
-1,548
-16% -$131K ﹤0.01% 537
2019
Q4
$820K Buy
+9,696
New +$820K ﹤0.01% 596
2019
Q3
Sell
-3,754
Closed -$322K 989
2019
Q2
$322K Sell
3,754
-2,682
-42% -$230K ﹤0.01% 845
2019
Q1
$572K Sell
6,436
-777
-11% -$69.1K ﹤0.01% 686
2018
Q4
$614K Buy
7,213
+1,633
+29% +$139K ﹤0.01% 618
2018
Q3
$541K Sell
5,580
-5,115
-48% -$496K ﹤0.01% 747
2018
Q2
$1.01M Buy
10,695
+5,812
+119% +$547K 0.01% 543
2018
Q1
$396K Sell
4,883
-1,329
-21% -$108K ﹤0.01% 807
2017
Q4
$554K Sell
6,212
-1,594
-20% -$142K ﹤0.01% 721
2017
Q3
$727K Buy
7,806
+2,836
+57% +$264K ﹤0.01% 666
2017
Q2
$451K Sell
4,970
-2,803
-36% -$254K ﹤0.01% 846
2017
Q1
$682K Buy
7,773
+1,895
+32% +$166K ﹤0.01% 724
2016
Q4
$487K Buy
5,878
+1,589
+37% +$132K ﹤0.01% 821
2016
Q3
$397K Sell
4,289
-890
-17% -$82.4K ﹤0.01% 895
2016
Q2
$403K Buy
+5,179
New +$403K ﹤0.01% 851
2016
Q1
Sell
-4,600
Closed -$482K 1107
2015
Q4
$482K Buy
4,600
+2,114
+85% +$222K ﹤0.01% 783
2015
Q3
$262K Sell
2,486
-3,540
-59% -$373K ﹤0.01% 990
2015
Q2
$824K Sell
6,026
-196
-3% -$26.8K 0.01% 667
2015
Q1
$775K Buy
+6,222
New +$775K 0.01% 713
2014
Q3
Sell
-7,099
Closed -$442K 1232
2014
Q2
$442K Buy
7,099
+1,621
+30% +$101K ﹤0.01% 939
2014
Q1
$374K Sell
5,478
-426
-7% -$29.1K ﹤0.01% 1009
2013
Q4
$415K Buy
5,904
+500
+9% +$35.1K ﹤0.01% 974
2013
Q3
$390K Sell
5,404
-900
-14% -$65K ﹤0.01% 954
2013
Q2
$351K Buy
+6,304
New +$351K ﹤0.01% 1089